Pacira Pharm Inc (PCRX)
26.68 -0.32 (-1.19%) 15:19 ET [NASDAQ]
26.64 x 12 26.69 x 30
Realtime by (Cboe BZX)
26.64 x 12 26.69 x 30
Realtime 26.77 -0.23 (-0.85%) 09:30 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | PCRX | GRAL | SNDX | ||
| Company | Pacira Pharm Inc | Grail Inc | Syndax Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 26.79 | 35.00 | 13.36 | ||
| High | 27.08 | 35.17 | 13.92 | ||
| Low | 26.38 | 33.13 | 13.14 | ||
| Last | 26.68 | 34.30 | 13.80 | ||
| Change | -0.32 | -2.51 | +0.10 | ||
| % Change | -1.19% | -6.82% | +0.73% | ||
| Volume | 435,812 | 756,067 | 1,575,498 | ||
| 20-Day Average Volume | 995,721 | 1,266,675 | 1,878,824 | ||
| Previous Close | 27.00 | 36.81 | 13.70 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 25.19 | 28.32 | 12.10 | ||
| 20-Day Raw Stochastic | 86.67% | 66.97% | 93.75% | ||
| 20-Day Relative Strength | 58.20% | 55.73% | 55.77% | ||
| Weighted Alpha | +73.54 | +0.84 | -31.05 | ||
| Today's Opinion | 100% Buy | 88% Buy | 40% Sell | ||
| Previous Opinion | 100% Buy | 72% Buy | 48% Sell | ||
| Last Month's Opinion | 80% Buy | 24% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.59% since 04/23/25 | +1.17% since 04/23/25 | +5.46% since 04/23/25 | ||
| Low | 25.23 on 04/24/25 | 33.13 on 04/30/25 | 12.91 on 04/24/25 | ||
| High | 27.31 on 04/29/25 | 40.92 on 04/28/25 | 13.98 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | +7.83% since 03/28/25 | +26.83% since 03/28/25 | +4.02% since 03/28/25 | ||
| Low | 21.79 on 04/07/25 | 20.44 on 04/07/25 | 9.66 on 04/09/25 | ||
| High | 27.64 on 04/08/25 | 40.92 on 04/28/25 | 13.98 on 04/29/25 | ||
| 3-Month | |||||
| %Chg | +2.36% since 01/30/25 | +8.39% since 01/30/25 | -3.52% since 01/30/25 | ||
| Low | 21.79 on 04/07/25 | 20.44 on 04/07/25 | 9.66 on 04/09/25 | ||
| High | 27.64 on 04/08/25 | 63.99 on 02/18/25 | 16.95 on 02/21/25 | ||
| 6-Month | |||||
| %Chg | +59.22% since 10/30/24 | +150.77% since 10/30/24 | -27.54% since 10/30/24 | ||
| Low | 16.00 on 11/18/24 | 13.22 on 10/31/24 | 9.66 on 04/09/25 | ||
| High | 27.64 on 04/08/25 | 63.99 on 02/18/25 | 22.50 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,249,452 | 1,299,106 | 1,178,803 | ||
| Shares Outstanding, K | 46,276 | 35,297 | 86,044 | ||
| Annual Sales | 700,970,000 | 125,600,000 | 23,680,000 | ||
| Annual Net Income | -99,560,000 | -2,027,010,000 | -318,760,000 | ||
| Last Quarter Sales | 187,250,000 | 38,250,000 | 7,680,000 | ||
| Last Quarter Net Income | 16,040,000 | -97,070,000 | -94,170,000 | ||
| 60-Month Beta | 0.71 | N/A | 1.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.91 on 02/27/25 | -1.86 on 02/20/25 | -1.10 on 03/03/25 | ||
| Latest Earnings Date | 05/08/25 | 05/15/25 | 05/05/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 11.80 | 0.00 | 0.00 | ||